Journal of Physiology & Pathology in Korean Medicine (동의생리병리학회지)

The Physiological Society of Korean Medicine and The Society of Pathology in Korean Medicine (대한동의생리학회·한의병리학회)
권호 표지
DOI QR코드

DOI QR Code

Development of the General Guideline for Clinical Trial of Moxibustion

뜸 임상시험 가이드라인 개발 연구

  • Kim, Hye Su (Department of Acupuncture & Moxibustion Medicine, Graduate School, Daejeon University) ;
  • Kim, So Yun (Cheong-ju Oriental Hospital of Daejeon University) ;
  • Yoo, Jeong Eun (Dunsan Korean Medicine Hospital of Daejeon University) ;
  • Lee, Eun Jung (Dunsan Korean Medicine Hospital of Daejeon University) ;
  • Kim, Young-Il (Dunsan Korean Medicine Hospital of Daejeon University) ;
  • Jung, In Chul (Dunsan Korean Medicine Hospital of Daejeon University)
  • 김혜수 (대전대학교 대학원 침구의학과) ;
  • 김소연 (대전대학교 청주한방병원) ;
  • 유정은 (대전대학교 둔산한방병원) ;
  • 이은정 (대전대학교 둔산한방병원) ;
  • 김영일 (대전대학교 둔산한방병원) ;
  • 정인철 (대전대학교 둔산한방병원)
  • Received : 2017.04.18
  • Accepted : 2017.08.23
  • Published : 2017.08.25
Download PDF
⟨ Previous Next ⟩

Abstract

In this study, we report on the procedure of developing a guideline for clinical research protocol using moxibustion. Systematic review of the literature about moxibustion was conducted as a preliminary study to make basic content. Review and consulting by experts from each field was conducted to improve the quality. And we made checklist by arranging keypoint of this guideline. This guideline, Moxibustion Randomized Controlled Clinical Trial Guideline(MOXRATE), aims to be a guide for future researchers in planning clinical study using moxibustion as an intervention. MOXRATE also reports on an ethical issues.

Keywords

References

  1. Park HJ, Son CG. Overview for moxibustion-related researches worldwide. Korean J Acupunct. 2008;25(3);167-74.
  2. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement : updated guidelines for reporting parallel group randomised trials. Int J Surg. 2012; 10(1):28-55. https://doi.org/10.1016/j.ijsu.2011.10.001
  3. MacPherson H, Altman DG, Hammerschlag R, Youping L, Taixiang W, Adrian W, David M. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture(STRICTA): extending the CONSORT statement. PLoS Med. 2010;7(6).
  4. Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C. Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement. Ann Intern Med. 2006;144(5):364-7. https://doi.org/10.7326/0003-4819-144-5-200603070-00013
  5. Cheng CW, Fu SF, Zhou QH, Wu TX, Shang HC, Tang XD, Liu ZS, Liu J, Lin ZX, Lao L, Lu AP, Zhang BL, Liu BY, Bian ZX. Extending the CONSORT Statement to moxibustion. J Integr Med. 2013;11(1):54-63. https://doi.org/10.3736/jintegrmed2013009
  6. Ma B, Chen ZM, Xu JK, Wang YN, Chen KY, Ke FY, Niu JQ, Li L, Huang CB, Zheng JX, Yang JH, Zhu QG, Wang YP. Do the CONSORT and STRICTA Checklists Improve the Reporting Quality of Acupuncture and Moxibustion Randomized Controlled Trials Published in Chinese Journals? A Systematic Review and Analysis of Trends. PLoS One. 2016;11(1).
  7. Lee HS, Cha SJ, Park HJ, Seo JC, Park JB, Lee HJ. Revised STandards for Reporting Intervetions in Clinical Trials of Acupuncture(STRICTA): extension the CONSORT statement. Korean J Acupunct. 2010;27(3):1-23.
  8. [In press] Kim SY, Park YC, Lee EJ, Jeon JH, Jung IC, Kim YI. Quality assessment of randomized controlled trials of moxibustion using STRICTOM and ROB. JAMS. 2017.
  9. Lynn MR. Determination and quantification of content validity. Nurs Res 1986;35:382-5.
  10. Zaslawski C. Ethical considerations for acupuncture and chinese herbal medicine clinical trials: a cross-cultural perspective. Evid-Based Complement Altern Med. 2010;7(3):295-301. https://doi.org/10.1093/ecam/nen055
  11. White AR, Filshie J, Cummings TM. International acupuncture research forum. Clinical trials of acupuncture: consensus recommendations for optimal treatment, sham controls and blinding. Complement Ther Med. 2001;9(4):237-45. https://doi.org/10.1054/ctim.2001.0489
  12. Korea Food and Drug Administration Herbal Medicine Policy Division. Evaluation guideline of herbal medicine clinical trial: antitussive expectorant medicine. Seoul. Korea Food and Drug Administration. 2007.
  13. Leem JT, Lee SH, Han GJ, Kim EJ, Seo BK, Kim TH, Lee JH. Review of Ethical and Scientific Aspects of Acupuncture Clinical Trials Pointed Out by Institutional Review Board a Part of Development Process of the Acupuncture and Moxibustion Clinical Research Guideline. The Acupuncture. 2015;32(2):11-21. https://doi.org/10.13045/acupunct.2015016